To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease

Summary

The purpose of this study is to evaluate whether treatment with single and multiple oral doses of AZD1446 for 1 week will have effect on Quantified Electroencephalography and Event-Related Potentials in patients with Alzheimers Disease. The total treatment period is 9 weeks, divided into 5 equally long sub-periods of 7 days and 4 wash-out periods of 7 days each.

Timeline

Start

2010-06

Primary completion

2011-03

Completion

2011-03

Outcome

Outcome not reported

Stopped (Enrollment): “Poor recruitment.”

Drugs

Indications